Literature DB >> 21270052

Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells.

M Cristina Nostro1, Farida Sarangi, Shinichiro Ogawa, Audrey Holtzinger, Barbara Corneo, Xueling Li, Suzanne J Micallef, In-Hyun Park, Christina Basford, Michael B Wheeler, George Q Daley, Andrew G Elefanty, Edouard G Stanley, Gordon Keller.   

Abstract

The generation of insulin-producing β-cells from human pluripotent stem cells is dependent on efficient endoderm induction and appropriate patterning and specification of this germ layer to a pancreatic fate. In this study, we elucidated the temporal requirements for TGFβ family members and canonical WNT signaling at these developmental stages and show that the duration of nodal/activin A signaling plays a pivotal role in establishing an appropriate definitive endoderm population for specification to the pancreatic lineage. WNT signaling was found to induce a posterior endoderm fate and at optimal concentrations enhanced the development of pancreatic lineage cells. Inhibition of the BMP signaling pathway at specific stages was essential for the generation of insulin-expressing cells and the extent of BMP inhibition required varied widely among the cell lines tested. Optimal stage-specific manipulation of these pathways resulted in a striking 250-fold increase in the levels of insulin expression and yielded populations containing up to 25% C-peptide+ cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270052      PMCID: PMC3035090          DOI: 10.1242/dev.055236

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  63 in total

1.  Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer.

Authors:  Nabeel Bardeesy; Kuang-Hung Cheng; Justin H Berger; Gerald C Chu; Jessica Pahler; Peter Olson; Aram F Hezel; James Horner; Gregory Y Lauwers; Douglas Hanahan; Ronald A DePinho
Journal:  Genes Dev       Date:  2006-11-15       Impact factor: 11.361

2.  FGF signaling is necessary for establishing gut tube domains along the anterior-posterior axis in vivo.

Authors:  Jessica Dessimoz; Robert Opoka; Jennifer J Kordich; Anne Grapin-Botton; James M Wells
Journal:  Mech Dev       Date:  2005-12-02       Impact factor: 1.882

3.  A method for genetic modification of human embryonic stem cells using electroporation.

Authors:  Magdaline Costa; Mirella Dottori; Koula Sourris; Pegah Jamshidi; Tanya Hatzistavrou; Richard Davis; Lisa Azzola; Steven Jackson; Sue Mei Lim; Martin Pera; Andrew G Elefanty; Edouard G Stanley
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

4.  Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells.

Authors:  Kevin A D'Amour; Anne G Bang; Susan Eliazer; Olivia G Kelly; Alan D Agulnick; Nora G Smart; Mark A Moorman; Evert Kroon; Melissa K Carpenter; Emmanuel E Baetge
Journal:  Nat Biotechnol       Date:  2006-10-19       Impact factor: 54.908

5.  FGF signal transduction and the regulation of Cdx gene expression.

Authors:  Iain D Keenan; R Michael Sharrard; Harry V Isaacs
Journal:  Dev Biol       Date:  2006-08-24       Impact factor: 3.582

6.  BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm.

Authors:  Valerie Gouon-Evans; Lise Boussemart; Paul Gadue; Dirk Nierhoff; Christoph I Koehler; Atsushi Kubo; David A Shafritz; Gordon Keller
Journal:  Nat Biotechnol       Date:  2006-11-05       Impact factor: 54.908

7.  Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells.

Authors:  Paul Gadue; Tara L Huber; Patrick J Paddison; Gordon M Keller
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-31       Impact factor: 11.205

8.  Directed differentiation of human embryonic stem cells towards a pancreatic cell fate.

Authors:  J H Shim; S E Kim; D H Woo; S K Kim; C H Oh; R McKay; J H Kim
Journal:  Diabetologia       Date:  2007-04-18       Impact factor: 10.122

9.  In vitro derivation of functional insulin-producing cells from human embryonic stem cells.

Authors:  Wei Jiang; Yan Shi; Dongxin Zhao; Song Chen; Jun Yong; Jing Zhang; Tingting Qing; Xiaoning Sun; Peng Zhang; Mingxiao Ding; Dongsheng Li; Hongkui Deng
Journal:  Cell Res       Date:  2007-04       Impact factor: 25.617

10.  FGF4 and retinoic acid direct differentiation of hESCs into PDX1-expressing foregut endoderm in a time- and concentration-dependent manner.

Authors:  Martina Johannesson; Anders Ståhlberg; Jacqueline Ameri; Fredrik Wolfhagen Sand; Karin Norrman; Henrik Semb
Journal:  PLoS One       Date:  2009-03-11       Impact factor: 3.240

View more
  197 in total

1.  The functional and molecular characterisation of human embryonic stem cell-derived insulin-positive cells compared with adult pancreatic beta cells.

Authors:  C L Basford; K J Prentice; A B Hardy; F Sarangi; S J Micallef; X Li; Q Guo; A G Elefanty; E G Stanley; G Keller; E M Allister; M C Nostro; M B Wheeler
Journal:  Diabetologia       Date:  2011-11-11       Impact factor: 10.122

2.  The importance of beta cell characterisation: generating human beta cells by differentiating human embryonic stem cells.

Authors:  G S Korbutt; T Y Yeung; C E Ellis
Journal:  Diabetologia       Date:  2011-12-07       Impact factor: 10.122

Review 3.  Understanding pancreas development for β-cell repair and replacement therapies.

Authors:  Aurelia Raducanu; Heiko Lickert
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

4.  New markers for tracking endoderm induction and hepatocyte differentiation from human pluripotent stem cells.

Authors:  Audrey Holtzinger; Philip R Streeter; Farida Sarangi; Scott Hillborn; Maryam Niapour; Shinichiro Ogawa; Gordon Keller
Journal:  Development       Date:  2015-10-22       Impact factor: 6.868

5.  Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.

Authors:  Stephen T Bartlett; James F Markmann; Paul Johnson; Olle Korsgren; Bernhard J Hering; David Scharp; Thomas W H Kay; Jonathan Bromberg; Jon S Odorico; Gordon C Weir; Nancy Bridges; Raja Kandaswamy; Peter Stock; Peter Friend; Mitsukazu Gotoh; David K C Cooper; Chung-Gyu Park; Phillip OʼConnell; Cherie Stabler; Shinichi Matsumoto; Barbara Ludwig; Pratik Choudhary; Boris Kovatchev; Michael R Rickels; Megan Sykes; Kathryn Wood; Kristy Kraemer; Albert Hwa; Edward Stanley; Camillo Ricordi; Mark Zimmerman; Julia Greenstein; Eduard Montanya; Timo Otonkoski
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

6.  Productive Infection of Human Embryonic Stem Cell-Derived NKX2.1+ Respiratory Progenitors with Human Rhinovirus.

Authors:  Robert A Jenny; Claire Hirst; Sue Mei Lim; Adam L Goulburn; Suzanne J Micallef; Tanya Labonne; Anthony Kicic; Kak-Ming Ling; Stephen M Stick; Elizabeth S Ng; Alan Trounson; Antonietta Giudice; Andrew G Elefanty; Edouard G Stanley
Journal:  Stem Cells Transl Med       Date:  2015-04-14       Impact factor: 6.940

Review 7.  Pluripotent stem cells in regenerative medicine: challenges and recent progress.

Authors:  Viviane Tabar; Lorenz Studer
Journal:  Nat Rev Genet       Date:  2014-02       Impact factor: 53.242

8.  High oxygen condition facilitates the differentiation of mouse and human pluripotent stem cells into pancreatic progenitors and insulin-producing cells.

Authors:  Farzana Hakim; Taku Kaitsuka; Jamiruddin Mohd Raeed; Fan-Yan Wei; Nobuaki Shiraki; Tadayuki Akagi; Takashi Yokota; Shoen Kume; Kazuhito Tomizawa
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

9.  Overexpression of PAX4 reduces glucagon expression in differentiating hESCs.

Authors:  Blair K Gage; Robert K Baker; Timothy J Kieffer
Journal:  Islets       Date:  2014       Impact factor: 2.694

10.  Notch 1 tumor expression is lacking in highly proliferative pancreatic neuroendocrine tumors.

Authors:  Markus Krausch; Feride Kroepil; Nadja Lehwald; Anja Lachenmayer; Matthias Schott; Martin Anlauf; Kenko Cupisti; Wolfram Trudo Knoefel; Andreas Raffel
Journal:  Endocrine       Date:  2012-12-07       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.